EAA Chapter France

The European Access Academy (EAA) aims to identify key challenges and provide sound input for the implementation of the EU HTA Regulation to help achieve the EC’s mission of improving patient access to life saving innovative technologies.

EAA's Chapter France is focusing on the national implementation of EU HTA and consequences for the various stakeholders in the French national context.

Convention of EAA's Chapter France

The French Perspective:

A multi-stakeholder glance into

the initial EU HTA Assessments

Le point de vue français : un aperçu multipartite des premières évaluations HTA de l'UE

September 18th, 2026 at Université Paris Cité

Thank you very much to all attendees for their excellent and valuable contributions and the insightful and thought-provoking discussions. We are particularly grateful to the speakers and moderators: Yannick Neuder, Diane Lastennet, Lionel Collet, Laure Guéroult-Accolas, Jean-Yves Blay, Auriane Cano-Chancel, Francis Megerlin, Bruno Falissard, Anne-Pierre Pickaert, Gilles Vassal, Nicolas Girard, Vincent Laugel, Étienne Lengliné and Jean-François Bergmann.

NOW Available for Download:

EAA Chapter France Proceedings

EAA's Chapter France is funded by AstraZeneca SAS, Novartis Pharma SAS, Pfizer, Roche SAS,

hosted by Université Paris Cité and supported by leem.